Form EFFECT Adverum Biotechnologies,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 11, 2025 |
| Accession Number: | 0001193125-25-312795 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- OKI Signs Supply Contract with Mitsubishi Heavy Industries for Towed Passive Sonar for Australia’s New General-Purpose Frigates
- Dashing Dogs Dental Named the Best Choice for No-Sedation Dog and Cat Teeth Cleaning in Fraser Valley
- Market Technology Acquisition Corp Announces Closing of $205,000,000 Initial Public Offering, Including Partial Exercise of Underwriters' Over-Allotment Option
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
